Orally disintegrating films, or ODFs, are thin sheets that melt rapidly against the oral mucosa, releasing their payload for absorption without the need to swallow. Conventional ODFs rely almost exclusively on hydrophilic polysaccharides such as pullulan, hydroxypropyl methylcellulose, and pregelatinized starch, which disintegrate quickly; published examples include hydroxypropyl cellulose films that vanish in water in about 12.5 seconds and hydroxypropyl methylcellulose formulations that break down in roughly 43 seconds. But these matrices carry little nutritional value, and protein hydrolysate alternatives are prohibitively expensive. Soy protein isolate, a widely available and inexpensive plant protein with excellent film-forming ability and a rich amino acid profile, seemed like an obvious candidate, except that its dense, flexible molecular packing causes films to disintegrate sluggishly in water, sometimes lagging far behind their polysaccharide competitors.

The team’s answer was β-cyclodextrin, a cyclic oligosaccharide with a hydrophobic interior cavity and a hydrophilic, hydroxyl-covered exterior. Cyclodextrins are workhorses in food and pharmaceutical science, used to emulsify, solubilize, mask unpleasant flavors, and protect sensitive bioactive compounds. Previous work by some of the same authors had shown that β-cyclodextrin could accelerate the disintegration of soy protein films by disrupting the tight packing of protein chains. The new study asked whether the molecule could do double duty: remodel the protein network for rapid release while also protecting ergothioneine, a sulfur-containing antioxidant first isolated in 1909 from the fungus Claviceps purpurea and produced by edible fungi and cyanobacteria.

Ergothioneine was a demanding guest. Its unusually low redox potential of −60 millivolts makes it resistant to autoxidation, and studies have shown it outperforms glutathione at scavenging hydroxyl radicals, peroxyl radicals, and singlet oxygen. Yet antioxidant activity in ergothioneine-containing systems is known to decline during thermal processing and storage, likely through oxidative degradation. The researchers cast films by dissolving 2.0 grams of soy protein isolate in water at 75 degrees Celsius, adding 10 milligrams of ergothioneine, 0.7 grams of D-sorbitol as a plasticizer, and β-cyclodextrin at 0, 5, 10, and 15 percent of the dry protein weight, then drying the solutions in Petri dishes at 40 degrees Celsius for eight hours.

Microscopy revealed how dramatically the additive reshaped the material. The pristine soy protein film was rough and inhomogeneous, riddled with micropores and aggregated particulate domains, while adding ergothioneine alone smoothed the surface, apparently by promoting the unfolding of protein polypeptide chains. The real transformation came at 10 percent β-cyclodextrin, where the films displayed an extremely smooth, dense, defect-free surface organized into a continuous reticular network. The authors attribute this to hydrogen bonding between the cyclodextrin’s abundant hydroxyl groups and the protein network, which suppresses pore formation during drying. At 15 percent, however, the strategy backfired: bright, angular crystalline aggregates appeared across the surface, evidence that excess cyclodextrin had exceeded its solubility limit and phase-separated into β-CD-rich crystalline domains, shattering the structural continuity of the protein matrix.

Those structural changes translated directly into performance. The water contact angle, a measure of surface wettability, fell from 63.77 degrees in the control film to 36.28 degrees at 10 percent cyclodextrin, reflecting a far more hydrophilic surface that welcomes water penetration. Tensile strength climbed from 10.37 megapascals in the control to 12.15 megapascals at the optimal loading, and elongation at break rose from 3.462 to 4.376 percent, meaning the films became both stronger and more flexible. Then came the headline result: in vitro disintegration time dropped from 31.67 seconds in the control to 15.46 seconds at 10 percent cyclodextrin, a 45 to 52 percent improvement across the cyclodextrin-containing formulations, comfortably meeting the sub-60-second benchmark for fast-disintegrating films. Intriguingly, the 15 percent formulation showed no significant further gain, because its added thickness lengthened the path water had to travel, canceling out its extra hydrophilicity.

The loading data told a similarly encouraging story. High-performance liquid chromatography showed that ergothioneine loading efficiency rose from 66.83 percent in films without cyclodextrin to 76.33 percent at the 10 percent level, with loading capacity peaking at 2.16 micrograms per milligram of film. Relative standard deviations across replicate films stayed below 4 percent, confirming that the solvent casting method produces reproducible, uniformly dosed films. Each standard 15-by-15-millimeter dosing unit carried about 16.21 micrograms of ergothioneine in the optimal formulation. Surface pH values for all films ranged from 5.55 to 6.48, safely within the range tolerated by oral tissue, and mucoadhesive forces were essentially unchanged at moderate additive levels, reaching 0.69 newtons only in the phase-separated 15 percent formulation, where crystalline protrusions increased contact area.

The protective half of the dual function emerged under stress. The team sealed films in ordinary plastic bags and stored them for 28 days at 40 degrees Celsius, 75 percent relative humidity, under continuous fluorescent light to simulate accelerated oxidative aging. Films containing ergothioneine alone watched their DPPH radical scavenging activity collapse from 83.47 percent on day zero to 40.86 percent by day 28, with ABTS activity falling in parallel from 85.21 to 41.74 percent. Films with 10 percent cyclodextrin retained 60.57 percent DPPH activity and 60.68 percent ABTS activity over the same period, significantly better than every other formulation. Spectroscopic characterization supported the mechanism: X-ray diffraction showed the amorphous protein film acquiring the characteristic crystalline peaks of β-cyclodextrin, while Fourier-transform infrared spectroscopy revealed strengthened hydrogen bonding bands at 3288, 1641, and 1537 reciprocal centimeters, along with new peaks marking the cyclodextrin skeleton. Thermogravimetric analysis showed the maximum decomposition temperature rising steadily with cyclodextrin loading, from 300.28 degrees Celsius in the control to a peak of 314.63 degrees, confirming a more thermally robust composite.

The authors are careful about how far the interpretation can go. Because the antioxidant assays measure total radical scavenging of the entire film matrix rather than residual ergothioneine concentration directly, and because no inclusion complex between cyclodextrin and ergothioneine was demonstrated, the improved retention may reflect reduced oxidative exposure through intermolecular interactions and a denser matrix rather than the specific stabilization of individual ergothioneine molecules. The disintegration tests also used distilled water rather than simulated saliva, and all evaluations were in vitro. Future work employing HPLC or LC-MS quantification of ergothioneine, phase-solubility analysis, differential scanning calorimetry, and two-dimensional NMR is needed to pin down the molecular fate of the antioxidant during storage.

Even with those caveats, the implications are considerable. The study breaks the disintegration barrier that has kept soy protein out of serious consideration for orally disintegrating films, and it does so with a cheap, food-grade cyclodextrin that simultaneously improves mechanical strength, thermal stability, and antioxidant retention. For the food and pharmaceutical industries, the platform suggests a practical route to delivering sensitive bioactive compounds, from ergothioneine to other oxidation-prone nutraceuticals, in a fast-dissolving, plant-protein-based format that adds nutritional value instead of diluting it. If longer-term storage studies and in vivo safety testing bear out the accelerated results, the humble soybean may find itself at the leading edge of oral thin-film technology, one 15-second melt on the tongue at a time.

Subject of Research: Development of soy protein isolate-based orally disintegrating films using β-cyclodextrin to enhance disintegration and protect ergothioneine

Article Title: Development of soy protein isolate-based orally disintegrating films: The dual role of β-Cyclodextrin in enhancing disintegration performance and ergothioneine stability

Article References: Zhou, Y., Du, X., Lv, C., Tian, Y., Guo, S., Guo, Z., & Wang, Z. (2026). Development of soy protein isolate-based orally disintegrating films: The dual role of β-Cyclodextrin in enhancing disintegration performance and ergothioneine stability. Food Chemistry: X, 39, Article 104451. https://doi.org/10.1016/j.fochx.2026.104451

Image Credits: AI Generated

DOI: 10.1016/j.fochx.2026.104451

Keywords: orally disintegrating films, soy protein isolate, β-cyclodextrin, ergothioneine, oral drug delivery, antioxidant stability, film disintegration, hydrogen bonding, plant protein, Food Chemistry: X, bioactive compound protection, solvent casting

Orally disintegrating films have garnered considerable attention over the past decade due to their rapid dissolution upon contact with saliva, bypassing the need for water and enhancing convenience, especially among pediatric and geriatric populations. However, the challenge remains to optimize these films’ texture, dissolution rate, and overall sensory acceptance without compromising structural integrity. The team led by Park, Ganbat, and Han tackled these challenges head-on by systematically evaluating diverse hydrocolloid matrices within ODF formulations.

Hydrocolloids, naturally occurring polysaccharides renowned for their water-binding capabilities and film-forming properties, serve as the backbone of many pharmaceutical delivery systems. The researchers meticulously assessed how different hydrocolloid types influence disintegration time, mechanical strength, and dissolution kinetics. Their study did not merely skim the surface but dove deep into understanding molecular interactions that govern how these polymers behave in the complex oral environment.

One of the standout revelations from the study was the distinct performance profile exhibited by gelatin-based films. Unlike starch or pectin counterparts, gelatin films demonstrated superior flexibility and a faster disintegration rate. This dual advantage arises from gelatin’s unique triple helix molecular structure, which untangles swiftly in the presence of saliva, resulting in enhanced bioavailability of the active compounds embedded within the film matrix.

Conversely, films incorporating pectin displayed extended disintegration times due to their gel-forming attributes, highlighting potential for sustained release applications. This characteristic positions pectin-based ODFs as candidates for delivering therapeutics that benefit from prolonged exposure to the oral mucosa, such as local analgesics or antifungals.

Furthermore, the research incorporated sensory evaluations, an often-overlooked aspect in pharmaceutical formulations. By engaging volunteer panels to assess mouthfeel, taste, and aftertaste, the scientists demonstrated that hydrocolloid choice profoundly impacts patient acceptability. Notably, films formulated with modified starch garnered favorable feedback for neutral taste and comfortable mouthfeel, an essential factor for daily compliance.

The dissolution studies revealed intriguing dynamics as well. The interaction of hydrocolloids with different saliva compositions dramatically influenced how the films broke down. This finding suggests a need to tailor ODF formulations to target demographics with varying saliva pH and enzymatic profiles, potentially opening avenues for personalized oral drug delivery platforms.

From a physicochemical standpoint, the study explored parameters such as tensile strength, elongation at break, and moisture uptake behavior. These metrics are critical in ensuring that ODFs maintain robustness during manufacturing, packaging, and handling while still disintegrating promptly upon administration. The comprehensive characterization conducted showcases how subtle modifications in hydrocolloid concentration can fine-tune these properties, fine-balance that pharmaceutical formulators have long strived to achieve.

The implications reach beyond pharmaceuticals into the rapidly expanding realm of functional foods and nutraceuticals. Orally disintegrating films infused with vitamins, probiotics, and plant extracts could leverage these optimized hydrocolloid matrices to deliver health benefits seamlessly and appeal to consumer desires for convenience and efficacy.

Of particular interest is the team’s investigation into the sensory masking capabilities of different hydrocolloids, addressing a significant hurdle in orally administered films—the often unpleasant flavor of active pharmaceutical ingredients (APIs). Their findings suggest that certain hydrocolloids can form protective matrices that delay the immediate release of bitter compounds, enhancing taste masking without sacrificing dissolution performance.

This research also highlights environmental considerations. By employing biodegradable and naturally derived hydrocolloids, the production of ODFs aligns with sustainability goals, reducing reliance on synthetic polymers that contribute to ecological burdens. The synergy between performance and environmental consciousness underscores the future trajectory of oral film technologies.

Advanced analytical techniques such as scanning electron microscopy (SEM) and Fourier-transform infrared (FTIR) spectroscopy were utilized to delineate the microstructural arrangement and chemical interactions within the hydrocolloid films. These insights elucidate how polymer-polymer and polymer-water interplays determine the release kinetics and mechanical behavior of the films.

The study’s comprehensive approach—integrating physicochemical testing, dissolution profiling, and sensory evaluation—sets a new benchmark for future investigations targeting patient-centric drug delivery solutions. By contextualizing hydrocolloid performance within the multifaceted demands of oral administration, this work transcends traditional formulation science and introduces a holistic paradigm.

Clinicians and pharmaceutical developers stand to benefit immensely from these findings as they provide actionable data to tailor ODFs for specific therapeutic areas, optimize dosing regimens, and enhance patient adherence. The elegance of hydrocolloid specialization within ODFs could pave the way for bespoke medication tailored not only to the active compound but also to individual patient preferences and physiological conditions.

Moreover, the scalability of these formulations and their compatibility with existing manufacturing technologies imply that commercialization hurdles can be minimized, accelerating the availability of next-generation orally disintegrating films in global markets.

In conclusion, the collaborative efforts of Park, Ganbat, and Han represent a seminal contribution to oral pharmacotechnics, unlocking hydrocolloid-specific performance metrics that will spearhead innovation in drug delivery. Their study eloquently underscores that the choice and manipulation of polymeric carriers are as critical as the active pharmaceutical agents themselves in dictating therapeutic success.

As the healthcare landscape inevitably shifts toward patient-centered, non-invasive, and accessible treatment modalities, orally disintegrating films formulated with precisely characterized hydrocolloids will emerge not merely as carriers but as sophisticated vehicles delivering optimized therapeutic experiences. This research heralds a new dawn for pharmaceutical technology, marrying scientific rigor with sensory finesse, and promising a healthier future delivered one film at a time.

Subject of Research:
Hydrocolloid-specific performance in orally disintegrating films, encompassing physicochemical properties, dissolution behavior, and sensory evaluation.

Article Title:
Hydrocolloid-specific performance of orally disintegrating films: physicochemical, dissolution, and sensory insights.

Article References:
Park, CH., Ganbat, C., & Han, JA. Hydrocolloid-specific performance of orally disintegrating films: physicochemical, dissolution, and sensory insights. Food Sci Biotechnol (2025). https://doi.org/10.1007/s10068-025-02066-9

Image Credits: AI Generated

DOI: 10.1007/s10068-025-02066-9

Keywords:
Orally disintegrating films, hydrocolloids, physicochemical properties, dissolution kinetics, sensory evaluation, drug delivery, film-forming polymers, taste masking, patient compliance, pharmaceutical technology